| 4830 |
Centers for Disease Control and Prevention |
Html |
en |
Features and initial assessment of the Italian Behavioral Risk Factor Surveillance System PASSI, 2007-2008 |
null |
| Field Epidemiology Training | 0.451662 |
| National Health Plan | 0.476005 |
| data | 0.514016 |
| public health interventions | 0.53736 |
| PASSI Coordinating Group | 0.509262 |
| PASSI interviewers | 0.487084 |
| PASSI data | 0.504179 |
| public health departments | 0.463315 |
| regional coordinating groups | 0.445954 |
| PASSI d’Argento | 0.470401 |
| public health surveillance | 0.476546 |
| behavioral risk factors | 0.449662 |
| refusal rate | 0.482231 |
| World Health Organization | 0.44528 |
| response rate | 0.544919 |
| ongoing surveillance | 0.441869 |
| Progressi Delle Aziende | 0.445544 |
| PASSI sample | 0.488143 |
| regional PASSI coordinators | 0.506695 |
| National Health | 0.4833 |
| health status | 0.481112 |
| data collection process | 0.474129 |
| health unit staff | 0.456623 |
| PASSI national pool | 0.543227 |
| PASSI results | 0.495912 |
|
| public health agencies | 0.457116 |
| Behavioral Risk Factor | 0.519495 |
| public health policy | 0.46979 |
| local health unit | 0.521494 |
| public health staff | 0.455222 |
| Epidemiology Training Program | 0.450714 |
| health promotion | 0.473998 |
| national coordinating group | 0.525673 |
| National Statistics Institute | 0.546109 |
| Risk Factor Surveillance | 0.543467 |
| regional public health | 0.484698 |
| public health infrastructures | 0.452861 |
| surveillance systems | 0.506736 |
| local health units | 0.672071 |
| public health | 0.985186 |
| PASSI | 0.737224 |
| National Institute | 0.613062 |
| public health actions | 0.473269 |
| Delle Aziende Sanitarie | 0.44554 |
| eligible units | 0.443544 |
| data collection | 0.485183 |
| local public health | 0.477063 |
| PASSI supervisors | 0.486748 |
| recent National Health | 0.481931 |
|
CLICK HERE |
| 5310 |
Centers for Disease Control and Prevention |
Html |
null |
Tuberculosis (TB) Vaccination |
Tuberculosis (TB) vaccine info for parents, public, and health care professionals |
|
|
CLICK HERE |
| 10826 |
Centers for Disease Control and Prevention |
Html |
en |
PrEP for HIV Prevention |
If you think you are at risk of getting HIV, ask your health care provider if PrEP is right for you. Along with other prevention methods like condoms, PrEP can offer good protection against HIV if taken every day. |
| ongoing substantial risk | 0.53757 |
| prevention options | 0.528727 |
| injection drug | 0.616852 |
| Mutually monogamous means | 0.527936 |
| health care provider | 0.661619 |
| heterosexual man | 0.474466 |
| needle-sharing injection drug | 0.542531 |
| repeat HIV test | 0.675777 |
| anal sex | 0.47891 |
| oral sex | 0.477488 |
| potential HIV exposure—such | 0.670886 |
| injection equipment | 0.549412 |
| postexposure prophylaxis | 0.47993 |
| HIV prevention methods | 0.697016 |
| STD testing | 0.475881 |
| Pre-exposure prophylaxis | 0.489051 |
| condoms | 0.482981 |
| greater protection | 0.474144 |
| PrEP support activities | 0.697295 |
| PrEP research | 0.632756 |
| sexual behaviors | 0.4743 |
| good protection | 0.482267 |
| PrEP education | 0.637371 |
| injection risk behaviors | 0.536444 |
|
| single high-risk event | 0.528437 |
| prevention strategy | 0.480776 |
| HIV infection status | 0.661869 |
| bisexual male partners | 0.528689 |
| Prescribe PrEP | 0.639798 |
| local health departments | 0.521198 |
| unknown HIV status | 0.676651 |
| sterile injection equipment | 0.54676 |
| illicit drugs | 0.473418 |
| HIV prevention efforts | 0.659067 |
| federally qualified health | 0.515744 |
| HIV risk reduction | 0.659717 |
| substantial risk | 0.692296 |
| PrEP | 0.928946 |
| people | 0.51694 |
| drug treatment | 0.538936 |
| PEP Q&A | 0.47658 |
| HIV protection | 0.605805 |
| PrEP awareness | 0.638871 |
| HIV | 0.944141 |
| mutually monogamous* relationship | 0.535629 |
| uninfected partner | 0.475223 |
| HIV testing | 0.679894 |
| drug treatment program | 0.535747 |
|
CLICK HERE |
| 11238 |
Centers for Disease Control and Prevention |
Html |
es |
Informe Anual a la Nación sobre el Estado del Cáncer, 1975-2008 |
Informe Anual a la Nación sobre el Estado del Cáncer, 1975-2008 |
| Nuevos casos | 0.31861 |
| Archivo Apple Quicktime | 0.325152 |
| Archivo RealPlayer | 0.315393 |
| adultos jóvenes | 0.315981 |
| campaña mujeres afroamericanas | 0.338131 |
| Archivo Microsoft PowerPoint | 0.326859 |
| Archivo Adobe PDF | 0.324727 |
| Investigaciones Resúmenes | 0.320701 |
| Estados Unidos | 0.958063 |
| Archivo Microsoft | 0.370728 |
| Archivo Microsoft Word | 0.326612 |
|
| suficiente actividad | 0.315827 |
| cáncer colorrectal | 0.877429 |
| cáncer prevención | 0.401026 |
| Informe Anual | 0.398053 |
| Archivo Zip Comprimido | 0.32495 |
| Archivo Microsoft Excel | 0.324665 |
| vida prevención | 0.317756 |
| Asociación Norteamericana | 0.31589 |
| mediana edad | 0.317458 |
| Comunicación Masiva | 0.315425 |
|
CLICK HERE |
| 11309 |
Centers for Disease Control and Prevention |
Html |
null |
Seguridad de la vacuna contra la influenza |
Información sobre la seguridad de la vacuna contra la influenza: preguntas y respuestas -- CDC |
|
|
CLICK HERE |
| 11577 |
Centers for Disease Control and Prevention |
Html |
en |
NER - Peer-Reviewed Biomonitoring Articles | NNAL |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 12123 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance for Preparing Ebola Treatment Centers | Ebola Hemorrhagic Fever |
null |
| direct patient contact | 0.487738 |
| U.S. Hospital Preparedness | 0.492137 |
| site visit | 0.50012 |
| public health authorities | 0.550991 |
| CDC Emergency Operations | 0.488726 |
| Ebola outbreak | 0.518566 |
| direct patient care | 0.496521 |
| Agency-registered hospital disinfectant | 0.478669 |
| sufficient PPE | 0.494659 |
| patients | 0.501181 |
| PPE donning/doffing procedure | 0.520301 |
| ebola virus disease | 0.720399 |
| patient care | 0.60363 |
| specific CDC guidance | 0.509878 |
| EVD | 0.556534 |
| CDC Ebola Response | 0.567068 |
| state public health | 0.569633 |
| local health authorities | 0.544903 |
| Ebola test result | 0.530193 |
| acute care hospitals | 0.544384 |
| public health agencies | 0.528036 |
| Ebola Assessment Hospitals | 0.56887 |
| CDC’s Interim | 0.493607 |
| health authorities | 0.555818 |
| PPE | 0.568054 |
|
| comprehensive care | 0.489529 |
| infection control | 0.580705 |
| critical care nurses | 0.478957 |
| Confirmed Ebola Virus | 0.566705 |
| PPE protocols | 0.4921 |
| local health department | 0.495422 |
| intrafacility patient transfer | 0.488479 |
| technical assistance | 0.50611 |
| local health | 0.669528 |
| local health departments | 0.647638 |
| waste management | 0.516359 |
| public health | 0.621019 |
| clinical care | 0.48185 |
| Ebola treatment centers | 0.98987 |
| Ebola treatment center | 0.64384 |
| local health officials | 0.492352 |
| additional PPE supplies | 0.522902 |
| Interim Guidance | 0.578006 |
| local public health | 0.494627 |
| patient room | 0.478495 |
| patient care areas | 0.499988 |
| healthcare workers | 0.502274 |
| PPE supplies | 0.527012 |
| current PPE shortages | 0.524488 |
|
CLICK HERE |
| 13102 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses Associated with Severe Human Disease and on the Use of Antiviral Medications for Chemoprophylaxis |
Guidance for follow-up and antiviral chemoprophylaxis of close contacts of cases of human infection with novel influenza A viruses associated with severe human disease, including H7N9 and HPAI H5N1. - CDC |
| avian influenza | 0.71971 |
| probable case | 0.369592 |
| influenza treatment | 0.36188 |
| limited non-sustained person-to-person | 0.35146 |
| novel influenza | 0.906777 |
| infection control | 0.307052 |
| non-sustained person-to-person transmission | 0.349043 |
| severe influenza | 0.372659 |
| inhaled zanamivir | 0.319158 |
| interim guidance | 0.335585 |
| exposure groups | 0.314801 |
| pandemic influenza | 0.347443 |
| oral oseltamivir | 0.316642 |
| probable novel influenza | 0.448353 |
| respiratory symptoms | 0.364611 |
| CDC’s Influenza | 0.359324 |
| human H5N1 virus | 0.33062 |
| pathogenic avian influenza | 0.373609 |
| probable cases | 0.319237 |
| CDC Influenza Division | 0.41004 |
| close contact | 0.390878 |
| Influenza Season | 0.360752 |
| influenza A virus | 0.5604 |
|
| New England journal | 0.448636 |
| Influenza Antiviral Medications | 0.436207 |
| World Health Organization | 0.320074 |
| H5N1 viruses | 0.307459 |
| seasonal influenza | 0.400431 |
| severe human disease | 0.494158 |
| acute uncomplicated influenza | 0.423076 |
| H5N1 case definitions | 0.344737 |
| virus infection | 0.478944 |
| antiviral chemoprophylaxis | 0.367805 |
| symptomatic H5N1 patient | 0.301832 |
| avian influenza home | 0.396145 |
| oseltamivir-resistant influenza | 0.34711 |
| human infections | 0.342757 |
| H7N9 virus | 0.310325 |
| seasonal influenza studies | 0.397509 |
| et al | 0.456578 |
| close contacts | 0.428221 |
| Avian Influenza AV | 0.373017 |
| H5N1 influenza morbidity | 0.412151 |
| influenza a viruses | 0.478027 |
| H5N1 virus infection | 0.378089 |
| human infection | 0.404497 |
|
CLICK HERE |
| 13422 |
Centers for Disease Control and Prevention |
Html |
en |
Housing Insecurity and the Association With Health Outcomesand Unhealthy Behaviors, Washington State, 2011 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| Unadjusted prevalence ratios | 0.556188 |
| Disease Epidemiology Supervisor | 0.550145 |
| State Behavioral Risk | 0.612708 |
| poor physical health | 0.627052 |
| daily activity | 0.587143 |
| public health practitioners | 0.620694 |
| Risk Factor Surveillance | 0.611201 |
| state-added ACE module | 0.550023 |
| binge drinking | 0.555855 |
| categorical variables | 0.555864 |
| high school education | 0.552517 |
| health risk behaviors | 0.890739 |
| poor health | 0.600465 |
| social determinants | 0.559114 |
| Housing affordability | 0.554564 |
| health outcomes | 0.559307 |
| current smokers | 0.549658 |
| Disease Control | 0.565105 |
| unadjusted prevalence estimates | 0.557038 |
| High housing costs | 0.57932 |
| demographic measures | 0.558537 |
| state-added Social Context | 0.554181 |
| housing insecurity | 0.994561 |
|
| Housing insecure respondents | 0.641839 |
| state-added BRFSS modules | 0.552488 |
| mental health problems | 0.581411 |
| health insurance coverage | 0.577887 |
| Washington State Behavioral | 0.612176 |
| Epidemic Intelligence Service | 0.587299 |
| Hispanic ethnicity | 0.557366 |
| random-digit–dialed telephone survey | 0.555251 |
| social desirability bias | 0.549847 |
| socioeconomic measures | 0.660556 |
| BRFSS excludes participants | 0.55077 |
| poor mental health | 0.627037 |
| doctor visits | 0.625038 |
| annual household income | 0.54968 |
| complex sampling design | 0.551335 |
| medical care | 0.55551 |
| Washington State Department | 0.587407 |
| Washington State | 0.63292 |
| delay doctor visits | 0.561576 |
| Washington respondents | 0.556863 |
| Behavioral Risk Factor | 0.612481 |
| Washington State BRFSS | 0.564805 |
| fair health status | 0.622129 |
|
CLICK HERE |
| 16242 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Poliomyelitis Eradication - Pakistan,January 2015-September 2016 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| high-risk areas | 0.487945 |
| supplementary immunization activities | 0.433829 |
| environmental surveillance | 0.734954 |
| polio eradication | 0.47638 |
| independent WPV1 transmission | 0.451812 |
| WPV1 response efforts | 0.438043 |
| oral poliovirus vaccine | 0.695786 |
| endemic wild poliovirus | 0.425815 |
| routine vaccination coverage | 0.501735 |
| FATA | 0.46965 |
| injectable inactivated polio | 0.426947 |
| wild poliovirus type | 0.532035 |
| AFP cases | 0.580743 |
| SIAs | 0.488866 |
| United Nations Children | 0.427447 |
| adequate stool specimens§ | 0.424321 |
| Pakistan | 0.608088 |
| children | 0.523425 |
| immunization activities | 0.435307 |
| WPV1-positive environmental surveillance | 0.434322 |
| national immunization campaign | 0.442456 |
| Balochistan | 0.425539 |
| nonpolio AFP cases | 0.511097 |
| WPV1 cases | 0.915366 |
|
| public health | 0.468963 |
| WPV1 patients | 0.427583 |
| routine immunization services | 0.660717 |
| supplemental immunization activities | 0.429953 |
| period | 0.441114 |
| World Health Organization | 0.61721 |
| South Waziristan | 0.443414 |
| environmental samples | 0.486442 |
| fewer WPV1 lineages | 0.436661 |
| type 2-containing OPV | 0.484673 |
| KP | 0.454469 |
| polio cases | 0.439161 |
| AFP surveillance quality | 0.463521 |
| newly confirmed WPV1 | 0.432281 |
| Emergency Operations Center | 0.491733 |
| acute flaccid paralysis | 0.697791 |
| public health practice | 0.431895 |
| AFP surveillance | 0.718798 |
| stool specimen timeliness | 0.602422 |
| adequate stool | 0.511034 |
| vaccine-derived poliovirus | 0.429116 |
| national routine vaccination | 0.439913 |
| environmental surveillance samples | 0.518952 |
|
CLICK HERE |